Mpox, previously known as monkeypox, has recently been declared a global health emergency by the World Health Organization (WHO). This marks the second time in just two years that mpox has reached this level of concern. But why has this happened, and what does it mean for people around the world? In this article, we will explore why mpox is once again a serious issue, what has led to this resurgence, and how worried you should be about this situation.
What Is Mpox?
Mpox is a viral disease caused by the monkeypox virus, which is related to the virus that causes smallpox. Although mpox is less deadly than smallpox, it can still cause serious illness. Symptoms of mpox include fever, headache, muscle aches, and a rash that often turns into painful sores. The virus spreads through close contact with an infected person or animal, or with materials contaminated by the virus, such as bedding.
Why Is Mpox an Emergency Again?
Mpox has been declared an emergency again primarily due to a sharp rise in cases in Central and East Africa, especially in the Democratic Republic of Congo (DRC). In 2024, the DRC alone reported over 14,000 cases and 511 deaths, which is particularly concerning because it represents a significant increase from previous years. Even more alarming is the fact that the virus has spread to countries like Burundi, Kenya, Rwanda, and Uganda, which had not seen cases before (UN News) (Health News Florida).
The strain of mpox responsible for this outbreak is more severe than the one that caused the 2022 global outbreak. Known as clade 1b, this strain is deadlier and spreads more easily, leading to greater concern among health officials. The WHO and Africa Centres for Disease Control and Prevention (CDC) have both issued alerts, calling for urgent action to control the spread of the virus (Nature).
How Did This Happen?
The resurgence of mpox is partly due to weaknesses in the healthcare and surveillance systems in the affected regions. In many parts of Central Africa, healthcare infrastructure is underdeveloped, making it difficult to detect and respond to outbreaks quickly. Additionally, there is a lack of vaccines and treatments available in these regions. While high-income countries were able to deploy vaccines during the 2022 outbreak, African nations have struggled to secure enough doses to protect their populations (Nature).
Another factor contributing to the spread is the movement of people within and between countries, especially in areas with limited healthcare resources. As people travel, they may unknowingly carry the virus to new areas, leading to further spread.
How Worried Should You Be?
For most people outside the affected regions, the immediate risk of mpox is low. The current outbreak is primarily concentrated in Central and East Africa, and health officials are working hard to prevent the virus from spreading further. However, it is still important to be aware of the situation, especially if you are traveling to or living in areas where mpox is spreading.
If you are in or traveling to one of the affected regions, there are steps you can take to protect yourself. These include avoiding close contact with people who are sick, practicing good hygiene, and following any travel advisories or health guidelines issued by local authorities.
Even if you are not in an affected area, staying informed is crucial. Health situations can change rapidly, and being aware of the latest developments can help you make informed decisions about your health and safety.
What Is Being Done to Control the Outbreak?
In response to the outbreak, the WHO and Africa CDC are working closely with governments and other organizations to mobilize resources and coordinate efforts to control the virus. This includes increasing surveillance to detect new cases, securing vaccines and treatments, and improving healthcare infrastructure in the affected regions (Health News Florida) (Nature).
However, there are significant challenges to these efforts. For example, the Africa CDC is negotiating to obtain 200,000 doses of the mpox vaccine, but experts estimate that at least 10 million doses are needed to effectively control the outbreak. Additionally, delivering these vaccines to remote areas with poor healthcare infrastructure is a complex task that will require significant resources and coordination (Nature).
